In multiple myeloma, one may postulate that tumor cell-secreted 2DDR upregulates CIITA expression in myeloid cells and increases osteoclast differentiation through activation of the c-fms/RANKL signaling. The gene discussed is CSF1R; the disease is plasma cell myeloma.